183 related articles for article (PubMed ID: 4913937)
1. [Relation of monoamines to mental disorders].
Rysánek K
Act Nerv Super (Praha); 1970; 12(2):97-108. PubMed ID: 4913937
[No Abstract] [Full Text] [Related]
2. Biochemical abnormalities associated with schizophrenia.
Smythies JR
Br J Psychiatry; 1975; Spec No 9():41-7. PubMed ID: 1102037
[No Abstract] [Full Text] [Related]
3. Biogenic amines and psychiatry.
Aust N Z J Psychiatry; 1971 Mar; 5(1):4-9. PubMed ID: 4946453
[No Abstract] [Full Text] [Related]
4. [SEROTONIN AND PSYCHIATRY].
PELICIER Y
Pathol Biol; 1964 Nov; 12():1107-9. PubMed ID: 14224288
[No Abstract] [Full Text] [Related]
5. [Electrolyte changes and mental disorders].
Villani F; Andreoli V; Mangoni A
Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):7-31. PubMed ID: 4337777
[No Abstract] [Full Text] [Related]
6. Amines and abnormal mood.
Dewhurst WG
Proc R Soc Med; 1969 Nov; 62(11 Part 1):1102-7. PubMed ID: 5356863
[No Abstract] [Full Text] [Related]
7. Defects in monoamine metabolism and their possible importance in the pathogenesis of depressive syndromes.
Coppen A
Psychiatr Neurol Neurochir; 1969; 72(2):173-80. PubMed ID: 5792057
[No Abstract] [Full Text] [Related]
8. Amines, alerting and affect.
Weil-Malherbe H
Lancet; 1968 Jul; 2(7561):219-20. PubMed ID: 4173434
[No Abstract] [Full Text] [Related]
9. Monoamines and mental disease.
Sandler M
Proc R Soc Med; 1972 Jul; 65(7):584-5. PubMed ID: 5085927
[No Abstract] [Full Text] [Related]
10. [Biochemical psychotherories. Where do we stand in 1971? 1. Monoamine theories].
Giacobini E
Lakartidningen; 1971 Dec; 68(49):5699-712. PubMed ID: 5137389
[No Abstract] [Full Text] [Related]
11. The biochemistry of affective disorders.
Coppen A
Br J Psychiatry; 1967 Nov; 113(504):1237-64. PubMed ID: 4169954
[No Abstract] [Full Text] [Related]
12. [Monoamines and manic-depressive syndromes].
Tissot R
Schweiz Arch Neurol Neurochir Psychiatr; 1967; 100(2):487-98. PubMed ID: 4873952
[No Abstract] [Full Text] [Related]
13. [Endogenous hallucinogens].
Kanabus P; Frindt-Zajaczkowska A
Psychiatr Pol; 1974; 8(2):197-202. PubMed ID: 4830327
[No Abstract] [Full Text] [Related]
14. Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca.
Hillarp NA; Fuxe K; Dahlström A
Pharmacol Rev; 1966 Mar; 18(1):727-41. PubMed ID: 5904678
[No Abstract] [Full Text] [Related]
15. [Inadequacy of the monoamine oxidase system--the probable pathogenetic factor in schizophrenia (review)].
Kolpakov VG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(8):1254-63. PubMed ID: 4278558
[No Abstract] [Full Text] [Related]
16. The role of amines in the etiology of schizophrenia.
Faurbye A
Compr Psychiatry; 1968 Mar; 9(2):155-77. PubMed ID: 4873817
[No Abstract] [Full Text] [Related]
17. A biochemical survey of schizophrenia.
Brodsky L
Can Psychiatr Assoc J; 1970 Aug; 15(4):375-88. PubMed ID: 4915174
[No Abstract] [Full Text] [Related]
18. Theories of biological etiology of affective disorders.
Davis JM
Int Rev Neurobiol; 1970; 12():145-75. PubMed ID: 4918142
[No Abstract] [Full Text] [Related]
19. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
Andén NE
Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
[No Abstract] [Full Text] [Related]
20. The common pathophysiology of monaminergic psychoses: a new hypothesis.
Tissot R
Neuropsychobiology; 1975; 1(4):243-60. PubMed ID: 775359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
